Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis. (Q38743691)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

title

Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

author name string

T Kwak

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

K Drews-Elger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

A Ergonul

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

P C Miller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

G H Hwang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

D Zhao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

A Besser

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Y Yamamoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

H Yamamoto

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

D El-Ashry

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

J M Slingerland

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

B I Hudson

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

language of work or name

English

0 references

publication date

26 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

page(s)

1559-1572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27669433%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Diabetes mellitus and risk of breast cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

RAGE and RAGE ligands in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Common interactions between S100A4 and S100A9 defined by a novel chemical probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Structural Basis for Ligand Recognition and Activation of RAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Alternative splicing of the RAGE cytoplasmic domain regulates cell signaling and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

V domain of RAGE interacts with AGEs on prostate carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

AGE-RAGE system and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Genes that mediate breast cancer metastasis to lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

A multigenic program mediating breast cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Human S100A12: a novel key player in inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Receptor for Advanced Glycation End Products (RAGE) Prevents Endothelial Cell Membrane Resealing and Regulates F-actin Remodeling in a β-Catenin-dependent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Regulation of osteoclast function and bone mass by RAGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Stromal gene expression predicts clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Gene expression profiling of the tumor microenvironment during breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

RAGE signaling sustains inflammation and promotes tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Altered immune function during long-term host-tumor interactions can be modulated to retard autochthonous neoplastic growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

[S-100 beta protein in serum, a tumor marker in malignant melanoma-- current state of knowledge and clinical experience]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2016.324

New folate analogs of the 10-deaza-aminopterin series. Further evidence for markedly increased antitumor efficacy compared with methotrexate in ascitic and solid murine tumor models

31 March 2020

1 reference

12 December 2020

Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature

1 reference

12 December 2020

Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor

1 reference

12 December 2020

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

1 reference

12 December 2020